Table 4.
Estimated pharmacodynamic parameters for the suppressant effect of TF-505 on plasma DHT concentration in the six subjects administered the drug once daily for 7 days.
| Dose (mg) | IC50 (µg ml-1) | CV (%) |
|---|---|---|
| 12.5 | 1.74 | 165.6 |
| 25 | 1.49 | 156.2 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.